You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

328 Results
Drug
Other Name(s): Anandron® ()
Sep 2018
Drug
Other Name(s): Tasigna®
Jul 2025
Drug
Other Name(s): Tomudex®
Sep 2024
Drug
Other Name(s): Rituxan® , Truxima™ , Riximyo™ , Ruxience™ , Riabni™
Jun 2025
Drug
Other Name(s): Abraxane®
Dec 2024
Drug
Other Name(s): Jakavi®
Mar 2025
Drug
Other Name(s): Stivarga®
Nov 2023
Drug
Other Name(s): Istodax®
Mar 2023
Drug
Other Name(s): Atriance®
Apr 2024
Drug
Other Name(s): Cyramza®
Jan 2026
Regimen
Intent: Palliative
Funding:
New Drug Funding Program
    Nab-Paclitaxel - Metastatic Breast Cancer
Nov 2023
Regimen
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's Low Grade
Intent: Palliative
Funding:
New Drug Funding Program
    Rituximab (Biosimilar IV) - Single Agent - Indolent Lymphoma
Jun 2025

Pages